全文获取类型
收费全文 | 5186篇 |
免费 | 322篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 232篇 |
妇产科学 | 120篇 |
基础医学 | 571篇 |
口腔科学 | 43篇 |
临床医学 | 330篇 |
内科学 | 1280篇 |
皮肤病学 | 93篇 |
神经病学 | 575篇 |
特种医学 | 284篇 |
外科学 | 769篇 |
综合类 | 9篇 |
预防医学 | 291篇 |
眼科学 | 27篇 |
药学 | 394篇 |
中国医学 | 8篇 |
肿瘤学 | 476篇 |
出版年
2023年 | 54篇 |
2022年 | 44篇 |
2021年 | 105篇 |
2020年 | 92篇 |
2019年 | 109篇 |
2018年 | 234篇 |
2017年 | 168篇 |
2016年 | 184篇 |
2015年 | 205篇 |
2014年 | 218篇 |
2013年 | 316篇 |
2012年 | 326篇 |
2011年 | 247篇 |
2010年 | 192篇 |
2009年 | 162篇 |
2008年 | 235篇 |
2007年 | 205篇 |
2006年 | 189篇 |
2005年 | 211篇 |
2004年 | 198篇 |
2003年 | 153篇 |
2002年 | 140篇 |
2001年 | 95篇 |
2000年 | 71篇 |
1999年 | 107篇 |
1998年 | 38篇 |
1997年 | 20篇 |
1996年 | 16篇 |
1995年 | 23篇 |
1994年 | 22篇 |
1992年 | 117篇 |
1991年 | 122篇 |
1990年 | 93篇 |
1989年 | 84篇 |
1988年 | 87篇 |
1987年 | 75篇 |
1986年 | 77篇 |
1985年 | 65篇 |
1984年 | 45篇 |
1983年 | 34篇 |
1982年 | 17篇 |
1980年 | 20篇 |
1979年 | 46篇 |
1978年 | 26篇 |
1976年 | 18篇 |
1973年 | 27篇 |
1971年 | 17篇 |
1969年 | 20篇 |
1968年 | 16篇 |
1967年 | 18篇 |
排序方式: 共有5524条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Marco Maruzzo Umberto Basso Eugenio Borsatti Laura Evangelista Filippo Alongi Orazio Caffo Francesca Maines Sara Galuppo Rocco De Vivo Fable Zustovich Dario Palleschi Andrea Zivi Teodoro Sava Mariella Sorarù Roberto Iacovelli Maurizio Nicodemo Susanne Baier Lucia Fratino Vittorina Zagonel 《Clinical genitourinary cancer》2019,17(1):e187-e194
Background
Radium 223 was introduced for metastatic castration-resistant prostate cancer based on the results of a randomized controlled trial showing risk reduction for death and skeletal events. Our aim was to evaluate the outcome of patients receiving radium 223 in a real-world setting.Patients and Methods
We conducted a multicenter retrospective analysis in the Triveneto region of Italy.Results
One hundred fifty-eight patients received radium 223 in our region. After a median follow-up of 9.5 months, 75 patients died. The median overall survival (OS) was 14.2 months, and the median progression-free survival (PFS) was 6.2 months. Seventy-one (45%) patients achieved progression as best response. Thirty-seven (23%) patients stopped the treatment early because of progression. Eastern Cooperative Oncology Group performance status was prognostic for OS (18.4 vs. 12.3 vs. 7.5 months; 0 vs. 1, P = .0062; 0 vs. 2, P = .0002), whereas previous prostatectomy or docetaxel exposure were not. A neutrophil to lymphocytes ratio ≥ 3 significantly impacted OS (18.1 vs. 9.7 months; P < .001) and slightly impacted PFS (6.6 vs. 5.6 months; P = .05). Patients with a baseline alkaline phosphatase (ALP) value ≥ 220 U/L had worse OS and PFS (24.1 vs. 10.5 months; 7.2 vs. 5.5 months; P < .001). Patients with changes in ALP value achieved better OS (P = .029) and PFS (P = .002). There was no difference according to the line of therapy (0 vs. ≥ 1; P = .490). The main grade 3/4 toxicities were anemia, asthenia, and thrombocytopenia.Conclusion
This large real-world report confirms comparable OS and PFS data when compared with the pivotal study, as well as the predictive role of ALP and neutrophil to lymphocytes ratio. The definition of the optimal position of radium 223 in the treatment of metastatic castration-resistant prostate cancer has still to be defined. 相似文献5.
6.
Is interleukin 2 a neuromodulator in the brain? 总被引:5,自引:0,他引:5
A bidirectional flow of information exists between the CNS and the neuroendocrine and immune systems, representing an important homeostatic mechanism in the body. Lymphokines and other products of immunocompetent cells seem to play a crucial role in this communication and seem to exert powerful effects on neurones in the brain. In this article, Giuseppe Nisticò and Giovambattista De Sarro describe the central effects following interleukin 2 (IL-2) microinfusion into several areas of the rat brain. The locus coeruleus seems to be the main site in the brain through which IL-2 exerts soporific effects. In addition, the possible transducing mechanisms coupling IL-2 receptor stimulation and the electroencephalogram (EEG) spectrum power responses elicited from the locus coeruleus seem to involve stimulation of specific receptors coupled to adenylate cyclase through a Gi protein. 相似文献
7.
8.
Eugenia Cordelli Anna Maria Fresegna Alessia D'Alessio Patrizia Eleuteri Marcello Spanò Francesca Pacchierotti Paola Villani 《Toxicological sciences》2007,99(2):545-552
The increasing request of chemical safety assessment demands for the validation of alternative methods to reduce the resort to animal experimentation. Methods that evaluate reproductive toxicity are among those requiring the largest use of animals. Presently, no validated in vitro alternative exists for the assessment of reproductive toxicity. Mammalian sperm are sensitive targets of DNA-reactive chemicals, which form premutagenic adducts. Here, we propose a new method based on comet assay to detect DNA damage induced by potential germ cell mutagens in bull sperm available from assisted reproduction practices. In somatic cells, chemical-induced adducts can be revealed by comet assay that detects DNA breaks produced during adduct repair. Mature sperm, however, are devoid of repair enzymes, and adducts are processed only after fertilization. For this reason, comet assay is not sensitive to detect DNA lesions induced in sperm by most chemicals. To overcome such limitation, we developed a modified comet assay based on the addition of a protein extract from HeLa cells to agarose-embedded sperm on microscopic slides. To test the method, sperm were treated in vitro with methyl methanesulfonate (MMS) or melphalan (MLP) and comet assay was conducted both with and without protein supplementation. No effect of MMS or MLP was detected without protein supplementation; on the contrary, a clear-cut dose-dependent effect was measured after addition of the cell extract. These results represent a proof of concept of a novel in vitro mutagenicity test on sperm that could offer a promising approach to complement previously validated in vivo germ cell genotoxicity assays. 相似文献
9.
D Schiffer L Autilio-Gambetti A Chiò P Gambetti M T Giordana F Gullotta A Migheli M C Vigliani 《Journal of neuropathology and experimental neurology》1991,50(4):463-473
Several neurodegenerative diseases, including motor neuron disease (MND), are characterized by formation of abnormal cytoskeleton-derived inclusions which contain ubiquitin (Ubq). We have studied the distribution of Ubq in 26 cases of MND with light and electron microscopic immunocytochemistry. Ubiquitin-positive inclusions were found in neurons of anterior horns in most cases of amyotrophic lateral sclerosis (ALS) but were not present in other forms of MND. Ubiquitin immunoreactivity was observed in 10-15 nm intraneuronal filaments, which were not stained by antibodies to neurofilaments, and on dense bodies of dystrophic neurites throughout the neuropil of anterior horns and pyramidal tracts. Data analysis showed a trend toward lower percentage of Ubq-positive neurons in cases with longer duration of illness or lower number of neurons. A high percentage of Ubq-positive inclusions occurred in cases with an aggressive clinical course, suggesting that ubiquitination takes place at early stages of the disease. 相似文献
10.